SCHEMBL30407162

SCHEMBL30407162

CC(C)(C)OC(=O)CCCNC(=O)[C@H](NC(=O)OCc1ccccc1)[C@@H](NC(=O)OCc1ccccc1)C(=O)NCCOCCOCCOCCOCCC(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ SYK P43405 1/20 0.46
▸ MAPT P10636 1/20 0.45
▸ CAPN1 P07384 1/20 0.45
▸ CAPN2 P17655 1/20 0.45
▸ CTSS P25774 4/20 0.44
▸ CTSL P07711 3/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HTT P42858 2/20 0.43
▸ CTSB P07858 2/20 0.43
▸ CA2 P00918 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA1 P00915 1/20 0.41
▸ BCHE P06276 2/20 0.41
▸ ACHE P22303 2/20 0.41
▸ CACNA1F O60840 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29467718 0.97 CAPN1 (0.47) SMN1; SMN2LMNASYKMAPTCAPN1
SCHEMBL29548496 0.93 SMN1; SMN2 (0.47) SMN1; SMN2LMNASYKMAPTCAPN1
SCHEMBL29467638 0.93 SMN1; SMN2 (0.47) SMN1; SMN2LMNASYKMAPTCAPN1
SCHEMBL25331392 0.91 SMN1; SMN2 (0.49) SMN1; SMN2LMNASYKMAPTCAPN1
SCHEMBL23451372 0.91 SYK (0.54) LMNASYKMAPTCAPN1CAPN2
SCHEMBL23451373 0.91 SYK (0.54) LMNASYKMAPTCAPN1CAPN2
SCHEMBL30407736 0.89 HTT (0.57) SMN1; SMN2LMNACAPN1CAPN2CTSS
SCHEMBL31720396 0.88 SYK (0.51) LMNASYKMAPTCAPN1CAPN2
SCHEMBL29467603 0.88 SYK (0.51) LMNASYKMAPTCAPN1CAPN2
SCHEMBL29390915 0.88 SYK (0.51) LMNASYKMAPTCAPN1CAPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4426741-A1 BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE Hangzhou DAC Biotech Co., Ltd. (CN) 2024-09-11 — — EP disclosed
EP-4426729-A1 SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE Hangzhou Dac Biotech Co., Ltd. (CN) 2024-09-11 — — EP disclosed
WO-2023078021-A1 BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-05-11 — — WO disclosed
WO-2023078273-A1 SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-05-11 — — WO disclosed
Send feedback